Literature DB >> 32851865

Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis.

Weijia Cheng1, Xiao Li1, Dongling Liu1, Chaochu Cui1, Xianwei Wang1.   

Abstract

Endothelial-to-mesenchymal transition (EndMT) is a complex biological process by which endothelial cells lose their endothelial cell characteristics and acquire mesenchymal cell properties under certain physiological or pathological conditions. Recently, it has been found that EndMT plays an important role in the occurrence and development of fibrotic cardiovascular diseases. In this review, we first summarize the main induction pathways involved in EndMT process. In addition, we discuss the role of EndMT in fibrotic cardiovascular diseases and its potential implication in new therapeutic interventions.

Entities:  

Keywords:  TGF-β signaling; cardiac fibrosis; cardiovascular diseases; endothelial-to-mesenchymal transition; microRNAs; oxidative stress

Mesh:

Year:  2020        PMID: 32851865     DOI: 10.1177/1074248420952233

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  5 in total

Review 1.  Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction.

Authors:  Yong Wang; Juan Zhang; Zhen Wang; Cheng Wang; Dufang Ma
Journal:  Heart Fail Rev       Date:  2022-03-09       Impact factor: 4.214

Review 2.  The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.

Authors:  Qianman Peng; Dan Shan; Kui Cui; Kathryn Li; Bo Zhu; Hao Wu; Beibei Wang; Scott Wong; Vikram Norton; Yunzhou Dong; Yao Wei Lu; Changcheng Zhou; Hong Chen
Journal:  Cells       Date:  2022-06-03       Impact factor: 7.666

3.  Deciphering Cell-Type-Specific Gene Expression Signatures of Cardiac Diseases Through Reconstruction of Bulk Transcriptomes.

Authors:  Xiaobin Wu; Xingyu Zhao; Yufei Xiong; Ming Zheng; Chao Zhong; Yuan Zhou
Journal:  Front Cell Dev Biol       Date:  2022-02-18

Review 4.  Resveratrol against Cardiac Fibrosis: Research Progress in Experimental Animal Models.

Authors:  Dongmin Yu; Zhixian Tang; Ben Li; Junjian Yu; Wentong Li; Ziyou Liu; Chengnan Tian
Journal:  Molecules       Date:  2021-11-13       Impact factor: 4.411

Review 5.  miRNAs in Cardiac Myxoma: New Pathologic Findings for Potential Therapeutic Opportunities.

Authors:  Antonio Nenna; Francesco Loreni; Omar Giacinto; Camilla Chello; Pierluigi Nappi; Massimo Chello; Francesco Nappi
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.